Goldfarb, David S.
Modersitzki, Frank
Karafilidis, John
Li-McLeod, Josephine
Funding for this research was provided by:
Dicerna Pharmaceuticals
Article History
Received: 17 February 2023
Accepted: 25 March 2023
First Online: 17 April 2023
Declarations
:
: The study was supported by Dicerna Pharmaceuticals, Inc., a Novo Nordisk Company (Lexington, Massachusetts, USA). DSG: Consultant to Dicerna Pharmaceuticals, Inc., a Novo Nordisk Company, Alnylam, Arthrosi, Sumitovant, and Synlogic. Research support from Dicerna Pharmaceuticals, Inc., a Novo Nordisk Company, and Travere. FM: Consultant to Travere and Antares Pharma. JK: Employee of Dicerna Pharmaceuticals, Inc., a Novo Nordisk Company. JL-M: Paid consultant to Dicerna Pharmaceuticals, Inc., a Novo Nordisk Company.